Latest Prescription Drugs news
Acalabrutinib-Venetoclax Prolongs Survival in Previously Untreated Leukemia
posted February 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
posted February 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Olpasiran Leads to Significant Reduction in Oxidized Phospholipids
posted February 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Anifrolumab Tied to Less Organ Damage for Patients With Lupus
posted February 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Few Meet Major Clinical Response Criteria After Treatment Escalation for Lupus 
Postoperative Complications Elevated for Patients With Systemic Lupus Erythematosus 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy Related Articles
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing Monthly Specialist Briefings
Stay Connected
